Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Initiation

Initiation

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • News
  • Small Cap
  • Trading Ideas

Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It ‘Potentially Best-In-Class’ In Competitive Landscape

By Vandana Singh
July 11, 3:43 PM
Guggenheim Partners initiated coverage on Syndax Pharmaceuticals Inc (NASDAQ: SNDX) with a BUY rating and a 

INCY

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • News
  • Penny Stocks
  • Trading Ideas

Keep The Hunger On: Analyst Says Soleno Therapeutics’ Upside Potential Much Higher Than Downside Risk

By Vandana Singh
July 11, 3:38 PM
Cantor Fitzgerald has initiated coverage on Soleno Therapeutics Inc (NASDAQ: SLNO) with an Overweight rating and a 

SLNO

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • General
  • Initiation
  • Markets
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

Haverty Furniture’s Growth Opportunities Amid Housing Trends And Retail Bankruptcies: Analyst’s Take

By Shivani Kumaresan
July 11, 3:37 PM
Benchmark analyst Michael Legg initiated coverage on the shares of Haverty Furniture Companies Inc (NYSE: HVT) with a 

HVT

Read More
12 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For July 11, 2023

By Benzinga Insights
July 11, 11:02 AM
Upgrades For Generac Holdings Inc (NYSE:GNRC), Argus Research upgraded the previous rating of Hold to Buy. For the…

AA

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • Initiation
  • Large Cap
  • News
  • Trading Ideas

Analyst Is Bullish On Masimo Despite Proxy Overhang Concerns – Here’s Why

By Vandana Singh
July 10, 3:15 PM
Wells Fargo initiated coverage on Masimo Corporation (NASDAQ: MASI) with an Equal Weight rating and a 

AAPL

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Initiation
  • Large Cap
  • Markets
  • News
  • Price Target
  • Trading Ideas

First Solar Is Balancing Rising Capacity And Falling Prices: Analyst Initiates With Cautious Outlook

By Lekha Gupta
July 10, 1:47 PM
BMO Capital Markets analyst Ameet Thakkar initiated coverage on First Solar Inc (NASDAQ: FSLR) at Market Perform rating 

FSLR

Read More
11 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For July 10, 2023

By Benzinga Insights
July 10, 11:02 AM
Upgrades According to Morgan Stanley, the prior rating for ShockWave Medical Inc (NASDAQ:SWAV) was changed from Equal-Weight to…

AAN

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Initiation

Cava Group’s High Revenue Growth Attracts Analyst Praise, Stocks Jumps 10%

By Priya Nigam
July 10, 10:34 AM
Shares of Cava Group Inc (NYSE: CAVA) were up almost 10% during early trading on Monday, after its IPO last month that saw a nearly 100% return

CAVA

Read More
8 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For July 7, 2023

By Benzinga Insights
July 7, 11:01 AM
Upgrades For Credicorp Ltd (NYSE:BAP), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. For the…

ALG

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • General
  • Initiation
  • Markets
  • News
  • Price Target
  • Trading Ideas

Instructure Holdings Poised To Dominate Learning Management System Market: KeyBanc

By Nabaparna Bhattacharya
July 6, 3:01 PM
KeyBanc Capital Markets analyst Devin Au initiated coverage on Instructure Holdings, Inc. (NYSE: INST), with an Overweight rating and a 

INST

Posts pagination

Previous 1 … 39 40 41 … 272 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service